摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

ethyl 5-amino-3,4-dihydro-4-oxo-3-phenylthieno<3,4-d>pyridazine-1-carboxylate | 123542-47-2

中文名称
——
中文别名
——
英文名称
ethyl 5-amino-3,4-dihydro-4-oxo-3-phenylthieno<3,4-d>pyridazine-1-carboxylate
英文别名
ethyl 5-amino-4-oxo-3-phenyl-3,4-dihydrothieno[3,4-d]pyridazine-1-carboxylate;ethyl 5-amino-3,4-dihydro-4-oxo-3-phenylthieno[3,4-d]pyridazine-1-carboxylate;ethyl 5-amino-6-oxo-1-phenylthieno[3,4-d]pyridazine-3-carboxylate;5-Amino-4-oxo-3-phenyl-3,4-dihydro-thieno[3,4-d]pyridazine-1-carboxylic acid ethyl ester;ethyl 5-amino-4-oxo-3-phenylthieno[3,4-d]pyridazine-1-carboxylate
ethyl 5-amino-3,4-dihydro-4-oxo-3-phenylthieno<3,4-d>pyridazine-1-carboxylate化学式
CAS
123542-47-2
化学式
C15H13N3O3S
mdl
MFCD00197075
分子量
315.353
InChiKey
HLVGVGCIJRBRQW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    191 °C(Solv: 1,4-dioxane (123-91-1); ethanol (64-17-5))
  • 沸点:
    517.2±60.0 °C(Predicted)
  • 密度:
    1.46±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    22
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.13
  • 拓扑面积:
    113
  • 氢给体数:
    1
  • 氢受体数:
    6

SDS

SDS:058d448c5a4b364b2f4af0d1cd538f77
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Synthesis and Studies of Some Nitrogen and Sulfur Compounds
    作者:H. A. Soleiman、F. M. Abd El-Latif、M. A. Khalil、I. H. Elazab
    DOI:10.1080/10426500210672
    日期:2002.4.1
    Pyrazolo-, pyrimidino-, isoxazolo-, thiozolo-, and g -lactam incorporating thienopyridazine has been synthesised by cyclocondensation addition reaction and cycloaddition reaction of hydrazine hydrate phenyl hydrazine, hydroxylamine hydrochloride, urea, thiourea, mercapto acetic acid and monochloroacetyl chloride.
    通过水合肼苯肼、盐酸羟胺、尿素、硫脲、巯基乙酸和一氯乙酰氯的环缩合加成反应和环加成反应,合成了吡唑并、嘧啶基-、异恶唑并、噻唑并和 g-内酰胺并结合了噻吩并哒嗪。
  • Studies with condensed aminothiophenes: Further investigation on the reactivity of condensed aminothiophenes toward electron poor and acetylenes under microwave heating
    作者:Balkis Al-Saleh、Morsy A. El-Apasery
    DOI:10.1002/jhet.5570430306
    日期:2006.5
    The reaction of aminothienopyridazines 8a,b, aminothienocoumarin 13 and aminothienonaphthopyran 14 with enaminones 9, 17 and 20a,b under microwave irradiation affords either a mixture of both condensations C-1 alkylation products 15 and 16 or amino moiety alkylation and diethylamine elimination or only one of these products depending on nature of substituents on the thiophene ring. On the other hand
    aminothienopyridazines的反应8A,8B,aminothienocoumarin 13和aminothienonaphthopyran 14与烯胺酮9,17和20A,B在微波辐射下,得到两个都缩合的混合物C-1烷基化产物15和16只有一个或氨基部分烷基化和二乙胺去除或这些产物的种类取决于噻吩环上取代基的性质。另一方面,这些缩合的氨基噻吩与3-二甲基氨基丙烯醛的反应得到24和25。
  • Controlled microwave-assisted reactions: A facile synthesis of polyfunctionally substituted phthalazines as dual EGFR and PI3K inhibitors in CNS SNB-75 cell line
    作者:Maiiada Hassan Nazmy、Ramadan Ahmed Mekheimer、Mai E. Shoman、Mohamed Abo-Elsebaa、Mohamed Abd-Elmonem、Kamal Usef Sadek
    DOI:10.1016/j.bioorg.2022.105740
    日期:2022.5
    particular cell line, CNS SNB-75 cell line, but (5b) exhibited the highest growth inhibitory activity against CNS-SNB-75 cell line with (GI% = 108.81) and (IC50 = 3.703 ± 0.2) compared to erlotinib; (IC50 = 12.5 ± 0.68). It caused Pre-G1 apoptosis and growth arrest at S phase. It also increased percentage of the total apoptotic cells in CNS-SNB-75 cell line (39.26%) compared to control cells (2.17%)
    脑肿瘤是顽固的癌症,预后差,存活率令人失望。迫切需要具有更高疗效和更低耐药性的靶向癌症治疗药物。通过将 1-aryl-5-cyano-1,6-dihydro-4-methyl-6-oxo-3-pyridazine-carboxylate 与肉桂腈衍生物的环加成反应,开发了一种高效的多官能化酞嗪衍生物的一锅法合成方法。噻吩并[3,4- d ]哒嗪在受控微波加热下具有高产率的活化双键或三键系统。合成的酞嗪类化合物(5a-e、9和13 )通过体外试验测试了它们的体外抗癌活性。美国国家癌症研究所的一次剂量测定。只有酞嗪(5b ) 对来自所有子组的大多数测试癌细胞系显示出广谱抗肿瘤活性,平均 % GI = 22.61。有趣的是,所有测试的化合物都对特定细胞系 CNS SNB-75 细胞系表现出不同的生长抑制活性,但 ( 5b ) 对 CNS-SNB-75 细胞系表现出最高的生长抑制活性 (GI% =
  • AMINOTHIENOPYRIDAZINE INHIBITORS OF TAU ASSEMBLY
    申请人:Ballatore Carlo
    公开号:US20130029983A1
    公开(公告)日:2013-01-31
    The present invention is directed to methods of inhibiting a tauopathy in a patient by administration of a compound of formula I: Novel aminothienopyridazine compounds are also described.
    本发明涉及通过给予I型化合物来抑制患者的tau病变的方法:还描述了新的氨基噻吩吡嗪化合物。
  • A Microwave Assisted Diazo Coupling Reaction: The Synthesis of Alkylazines and Thienopyridazines
    作者:Saleh Al-Mousawi、Abdel-Zaher Elassar、Morsy Ahmed El-Apasery
    DOI:10.1080/10426500500536457
    日期:2006.8.1
    Heating diazoaminobenzene with active methylene compounds 1-3 in microwave oven in acetic acid, in the presence of hydrochloric acid, afforded the corresponding arylhydrazones 5-7. These reaction products were condensed with ethyl cyanoacetate in a domestic microwave oven after 1-2 minutes heating to yield the pyridazinones 8-12. Compounds 8c and 12 reacted with sulfur in basic DMF solution, in microwave oven using MORE technology to yield the thienopyridazinone 14 and 16 respectively. While 17 was produced when 8b was treated like wise with sulfur and DMF in the presence of piperidine. Compounds 16 coupled with aromatic diazonium salts to yield arylazo derivatives 21a-c.
查看更多

同类化合物

噻吩并[3,4-d]哒嗪-1-羧酸,5-氨基-3,4-二氢-3-(4-甲基苯基)-4-羰基-,乙基酯 1,4-二氯噻吩并[3,4-d]哒嗪 ethyl 5-[(4,4-dimethyl-2,6-dioxocyclohexylidenemethyl)amino]-4-oxo-3-phenyl-3,4-dihydrothieno[3,4-d]pyridazine-1-carboxylate 5,7-Dimethyl-thieno<3,4-d>pyridazin ethyl 5-amino-3-(4-bromophenyl)-4-oxo-3,4-dihydrothieno[3,4-d]pyridazine-1-carboxylate ethyl 3-(3-chlorophenyl)-5-(N-methylacetamido)-4-oxo-3,4-dihydrothieno[3,4-d]pyridazine-1-carboxylate ethyl 5-amino-4-oxo-3-(4-(trifluoromethoxy)phenyl)-3,4-dihydrothieno[3,4-d]pyridazine-1-carboxylate 5-amino-N-isopropyl-4-oxo-3-(4-(trifluoromethoxy)-phenyl)-3,4-dihydrothieno[3,4-d]pyridazine-1-carboxamide 5-amino-4-oxo-3-(4-(trifluoromethoxy)phenyl)-3,4-dihydrothieno[3,4-d]pyridazine-1-carboxylic acid 5-amino-3-(4-chlorophenyl)-4-oxo-3,4-dihydrothieno[3,4-d]pyridazine-1-carbohydrazide ethyl 5-amino-3-(2-chlorophenyl)-4-oxo-3,4-dihydrothieno-[3,4-d]pyridazine-1-carboxylate 7-amino-2-(4-chlorophenyl)-4-methylthieno[3,4-d]pyridazin-1(2H)-one 7-amino-4-methylthieno[3,4-d]pyridazin-1(2H)-one ethyl 5-amino-3-(4-fluorophenyl)-4-oxo-3,4-dihydrothieno[3,4-d]pyridazine-1-carboxylate 7-amino-4-methyl-2-(pyridin-3-yl)thieno[3,4-d]pyridazin-1(2H)-one 7-amino-2-benzyl-4-methylthieno[3,4-d]pyridazin-1(2H)-one 7-amino-4-methyl-2-(2,2,2-trifluoroethyl)thieno[3,4-d]pyridazin-1(2H)-one 7-amino-4-methyl-2-(pyridin-2-yl)thieno[3,4-d]pyridazin-1(2H)-one N,N-dimethyl-N'-(7-methyl-4-oxo-3-p-tolyl-1-p-tolylazo-3,4-dihydrothieno[3,4-d]pyridazin-5-yl)-formamidine ethyl 5-amino-4-oxo-3-(o-tolyl)-3,4-dihydrothieno[3,4-d]pyridazine-1-carboxylate 7-amino-2-isopropyl-4-methylthieno[3,4-d]pyridazin-1(2H)-one ethyl 5-amino-4-oxo-3-(4-(trifluoromethylsulfonyloxy)phenyl)-3,4-dihydrothieno[3,4-d]pyridazine-1-carboxylate ethyl 5-amino-3-(4-bromophenyl)-4-oxo-3,4-dihydrothieno[3,4-d]pyridazine-1-carboxylate 5-amino-3-(4-chlorophenyl)-N-methyl-4-oxo-3,4-dihydrothieno[3,4-d]pyridazine-1-carboxamide 5-amino-3-(4-chlorophenyl)-N,N-dimethyl-4-oxo-3,4-dihydrothieno[3,4-d]pyridazine-1-carboxamide 5-amino-3,4-dihydro-3-p-tolylthieno<3,4-d>-pyridazin-1-carboxylic acid hydrazide 7-amino-2-cyclohexyl-4-methylthieno[3,4-d]pyridazin-1(2H)-one 5-amino-3-(4-hydroxyphenyl)-4-oxo-3,4-dihydrothieno[3,4-d]pyridazine-1-carboxylic acid ethyl 5-amino-3-(4-hydroxyphenyl)-4-oxo-3,4-dihydrothieno[3,4-d]pyridazine-1-carboxylate 7-amino-2-p-tolyl-2H-thieno[3,4-d]pyridazin-1-one <3,4-d>-Thienopyridazin 5-amino-3-(3-chlorophenyl)-N-isopropyl-4-oxo-3,4-dihydrothieno[3,4-d]pyridazine-1-carboxamide ethyl 5-amino-3-(3-chlorophenyl)-4-oxo-3,4-dihydrothieno-[3,4-d]pyridazine-1-carboxylate 5-amino-3-(3-chlorophenyl)-4-oxo-3,4-dihydrothieno[3,4-d]pyridazine-1-carboxylic acid ethyl 5-(butylamino)-3-(3-chlorophenyl)-4-oxo-3,4-dihydrothieno[3,4-d]pyridazine-1-carboxylate butyl 5-(butylamino)-3-(3-chlorophenyl)-4-oxo-3,4-dihydrothieno[3,4-d]pyridazine-1-carboxylate ethyl 3-(3-chlorophenyl)-4-oxo-5-(2,2,2-trifluoroacetamido)-3,4-dihydrothieno[3,4-d]pyridazine-1-carboxylate ethyl 5-((tert-butoxycarbonyl)amino)-3-(3-chlorophenyl)-4-oxo-3,4-dihydrothieno[3,4-d]pyridazine-1-carboxylate ethyl 5-(benzylamino)-3-(3-chlorophenyl)-4-oxo-3,4-dihydrothieno[3,4-d]pyridazine-1-carboxylate ethyl 3-(3-chlorophenyl)-5-(methylamino)-4-oxo-3,4-dihydrothieno[3,4-d]pyridazine-1-carboxylate 5-amino-3-(4-bromophenyl)-4-oxo-3,4-dihydrothieno[3,4-d]pyridazine-1-carboxylic acid 5-amino-3-(4-bromophenyl)-N-isopropyl-4-oxo-3,4-dihydrothieno[3,4-d]pyridazine-1-carboxamide 5-amino-3-[4-(3-(18F)fluoranylpropoxy)phenyl]-4-oxo-N-propan-2-ylthieno[3,4-d]pyridazine-1-carboxamide tert-butyl N-[3-[4-(2-fluoroethoxy)phenyl]-4-oxo-1-(propan-2-ylcarbamoyl)thieno[3,4-d]pyridazin-5-yl]carbamate tert-butyl N-[3-(4-hydroxyphenyl)-4-oxo-1-(propan-2-ylcarbamoyl)thieno[3,4-d]pyridazin-5-yl]carbamate 5-amino-3-[4-(3-fluoro-2-hydroxypropoxy)phenyl]-4-oxo-N-propan-2-ylthieno[3,4-d]pyridazine-1-carboxamide Tert-butyl 5-amino-3-[4-(2-fluoroethoxy)phenyl]-4-oxothieno[3,4-d]pyridazine-1-carboxylate 5-amino-3-[4-(3-fluoropropoxy)phenyl]-4-oxo-N-propan-2-ylthieno[3,4-d]pyridazine-1-carboxamide 5-amino-3-[4-(2-(18F)fluoranylethoxy)phenyl]-4-oxo-N-propan-2-ylthieno[3,4-d]pyridazine-1-carboxamide 5-amino-3-(4-chlorophenyl)-N-cyclopropyl-4-oxo-3,4-dihydrothieno[3,4-d]pyridazine-1-carboxamide